Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Spravato
Recent news which mentions Spravato
Pharma Giant Johnson & Johnson Asks FDA To Approve Esketamine Nasal Spray For Treatment-Resistant Depression
July 23, 2024
Tickers
JNJ
NEWS
Tags
TDR
News
Bill Martin
From
Benzinga
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
May 18, 2024
Tickers
ABBV
AMGN
CURLF
JAZZ
Tags
TEVA
ABBV
Spravato
From
Benzinga
Johnson & Johnson's Q3 2023: $21.3B Rise In Sales, 'Sharpened Focus' On Innovation & Biotech Solutions
October 17, 2023
Tickers
JNJ
Tags
Benzinga
Cannabis
Markets
From
Benzinga
Sales Of Johnson & Johnson Esketamine Drug Spravato Rise Nearly 100% Year Over Year
July 20, 2023
Tickers
JNJ
Tags
contributors
Ketamine
FDA
From
Benzinga
Delic Holdings Shares Corporate Updates: Revenues Grow As Ketamine Clinic Chain Continues Expansion
July 22, 2022
Tickers
DELCF
NAD
Tags
Spravato
Psychedelics
Market News
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.